宁科生物
(600165)
| 流通市值：24.55亿 | | | 总市值：54.13亿 |
| 流通股本：7.33亿 | | | 总股本：16.16亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 274,368,872.09 | 117,651,934.46 | 444,481,369.66 | 327,352,388.72 |
| 营业总成本 | 353,575,429.53 | 136,912,848.55 | 678,172,087.77 | 513,802,317.45 |
| 其他经营收益 | | | | |
| 营业利润 | -132,116,834.33 | -63,510,847.76 | -110,418,305.94 | -239,492,575.4 |
| 利润总额 | -132,439,840.06 | -63,578,102.76 | -157,976,318.19 | -281,782,357.55 |
| 净利润 | -132,395,868.66 | -63,811,423.35 | -162,893,275.97 | -281,678,613.85 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | -132,395,868.66 | -63,811,423.35 | -162,893,275.97 | -281,678,613.85 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 612,245,020.45 | 711,961,097.93 | 791,767,827.27 | 317,543,319.58 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,729,075,616.92 | 1,693,627,078.93 | 1,698,285,405.49 | 1,908,514,814.18 |
| 资产总计 | 2,341,320,637.37 | 2,405,588,176.86 | 2,490,053,232.76 | 2,226,058,133.76 |
| 流动负债: | | | | |
| 流动负债合计 | 262,304,804.05 | 263,195,017.14 | 285,625,523.64 | 1,995,208,982.31 |
| 非流动负债: | | | | |
| 非流动负债合计 | 875,391,610.47 | 870,184,491.56 | 868,407,617.61 | 272,361,646.53 |
| 负债合计 | 1,137,696,414.52 | 1,133,379,508.7 | 1,154,033,141.25 | 2,267,570,628.84 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,075,477,536.61 | 1,143,630,810.69 | 1,207,946,343.83 | -179,185,719.7 |
| 股东权益合计 | 1,203,624,222.85 | 1,272,208,668.16 | 1,336,020,091.51 | -41,512,495.08 |
| 负债和股东权益合计 | 2,341,320,637.37 | 2,405,588,176.86 | 2,490,053,232.76 | 2,226,058,133.76 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 188,461,022.22 | 74,545,125.4 | 280,821,679.8 | 203,697,453.39 |
| 经营活动现金流出小计 | 391,459,628.88 | 219,057,372.75 | 654,224,062.38 | 440,182,308.51 |
| 经营活动产生的现金流量净额 | -202,998,606.66 | -144,512,247.35 | -373,402,382.58 | -236,484,855.12 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | - | - | 1,140,000 | 1,054,735 |
| 投资活动现金流出小计 | 51,043,349.9 | 25,073,192.49 | 271,166,587.99 | 45,171,315.35 |
| 投资活动产生的现金流量净额 | -51,043,349.9 | -25,073,192.49 | -270,026,587.99 | -44,116,580.35 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 114,964,570.21 | 250,916.67 | 1,681,645,825.72 | 327,000,000 |
| 筹资活动现金流出小计 | 129,960,763.6 | 17,292,780.77 | 587,509,321.68 | 46,728,922.14 |
| 筹资活动产生的现金流量净额 | -14,996,193.39 | -17,041,864.1 | 1,094,136,504.04 | 280,271,077.86 |
| 汇率变动对现金及现金等价物的影响 | -95,701.68 | -30,920.6 | 199,229.26 | 71,082.01 |
| 现金及现金等价物净增加额 | -269,133,851.63 | -186,658,224.54 | 450,906,762.73 | -259,275.6 |
| 期末现金及现金等价物余额 | 189,962,926.22 | 272,493,014.61 | 459,096,777.85 | 8,310,031.25 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -269,133,851.63 | - | 450,906,762.73 | - |